AUSAF - Australis completes stage one of Green Therapeutics acquisition

Australis Capital ([[AUSAF]] -0.6%) completes the first stage of the transaction to acquire Green Therapeutics.The transaction to complete in two parts, the first, now closed, being the acquisition of a subsidiary of GT( containing a number of unregulated assets including the GT brands and certain ancillary agreements including brand licensing and management agreements).Subsequently, company will complete the acquisition of GT itself.Completion of the transaction marks the company's entry into the U.S. cannabis space as an operator.Accretive transaction adds high-margin revenues and award-winning brands.

For further details see:

Australis completes stage one of Green Therapeutics acquisition